| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/HUM.2010.187 |
| P698 | PubMed publication ID | 21261460 |
| P50 | author | Youngchul Sung | Q112576717 |
| P2093 | author name string | Jung Yeon Lim | |
| Sin-Soo Jeun | |||
| Sang-Hoon Park | |||
| Chang Hyun Jeong | |||
| Chung Heon Ryu | |||
| Seong Muk Kim | |||
| Soon A Park | |||
| Wan-Soo Yoon | |||
| Won-il Oh | |||
| P433 | issue | 6 | |
| P921 | main subject | interleukins | Q194908 |
| gene therapy | Q213901 | ||
| human umbilical cord mesenchymal stem cell | Q107296600 | ||
| P304 | page(s) | 733-743 | |
| P577 | publication date | 2011-03-23 | |
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells | |
| P478 | volume | 22 |
| Q34022048 | Adenoviral vector-mediated gene therapy for gliomas: coming of age. |
| Q26866276 | Anti-angiogenic gene therapy in the treatment of malignant gliomas |
| Q52608756 | Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment. |
| Q34975310 | Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System |
| Q38958467 | CRM197 in Combination With shRNA Interference of VCAM-1 Displays Enhanced Inhibitory Effects on Human Glioblastoma Cells |
| Q28080710 | Cell or cell membrane-based drug delivery systems |
| Q58707289 | Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas |
| Q34318157 | Current status of gene therapy for brain tumors. |
| Q33670136 | Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma |
| Q38043528 | Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. |
| Q38090923 | Encapsulated stem cells for cancer therapy |
| Q42391294 | Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse |
| Q38378499 | Engineering Stem Cells for Biomedical Applications. |
| Q27026414 | Engineering mesenchymal stem cells for regenerative medicine and drug delivery |
| Q28082016 | Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier. |
| Q40080450 | Gene Delivery Approaches for Mesenchymal Stem Cell Therapy: Strategies to Increase Efficiency and Specificity |
| Q37539525 | Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice |
| Q94957197 | Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication |
| Q39352864 | Glioma cells promote the expression of vascular cell adhesion molecule-1 on bone marrow-derived mesenchymal stem cells: a possible mechanism for their tropism toward gliomas |
| Q38139850 | Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors |
| Q50506059 | Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice. |
| Q52564728 | IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer. |
| Q39443502 | Imaging of human mesenchymal stromal cells: homing to human brain tumors |
| Q26853431 | Immunotherapeutic organoids: a new approach to cancer treatment |
| Q38921024 | Inflammatory Chemokines MIP-1δ and MIP-3α Are Involved in the Migration of Multipotent Mesenchymal Stromal Cells Induced by Hepatoma Cells |
| Q53107743 | Interleukin-12B rs3212227 polymorphism and cancer risk: a meta-analysis. |
| Q64105864 | Joint bioinformatics analysis of underlying potential functions of hsa-let-7b-5p and core genes in human glioma |
| Q34230447 | Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion |
| Q47109590 | Mesenchymal stem cells as therapeutic agents and in gene delivery for the treatment of glioma*. |
| Q59790772 | Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review |
| Q26799013 | Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities |
| Q38715077 | Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas |
| Q37975113 | Multipotent mesenchymal stromal cell therapy and risk of malignancies |
| Q64064068 | Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far |
| Q90292756 | New Insights Into Implementation of Mesenchymal Stem Cells in Cancer Therapy: Prospects for Anti-angiogenesis Treatment |
| Q39190753 | Retrovirus-mediated transduction of a cytosine deaminase gene preserves the stemness of mesenchymal stem cells |
| Q92966660 | Rodent Glioma Models: Intracranial Stereotactic Allografts and Xenografts |
| Q38245163 | Stem cell-based therapies for cancer treatment: separating hope from hype |
| Q38855638 | Stem cell-based therapies for tumors in the brain: are we there yet? |
| Q26771835 | Stem cells as cellular vehicles for gene therapy against glioblastoma |
| Q34240433 | Stem cells as therapeutic vehicles for the treatment of high-grade gliomas |
| Q37420576 | Strategies in gene therapy for glioblastoma. |
| Q59797883 | The Dynamic Roles of Mesenchymal Stem Cells in Colon Cancer |
| Q36527593 | The art of gene therapy for glioma: a review of the challenging road to the bedside |
| Q36059696 | The homing of human cord blood stem cells to sites of inflammation: unfolding mysteries of a novel therapeutic paradigm for glioblastoma multiforme |
| Q36294870 | The liberation of CD44 intracellular domain modulates adenoviral vector transgene expression |
| Q37995017 | Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives |
| Q42654111 | Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype. |
Search more.